The beleaguered chief executive of biotech giant Amgen Inc. confronted an often testy group of shareholders Wednesday, his first annual meeting with investors since the company's fortunes took a hard turn last summer.
"Last year was awful. I deeply, deeply regret that," Kevin Sharer said, appearing calm and confident during an hour long presentation to an audience of several hundred at the Four Seasons Hotel in Westlake Village.
He also sought to reassure investors. Sharer said the company was off to a good start this year and suggested that many of Amgen's woes should be viewed along with problems affecting all drug companies. "I'm not making any excuses . . . but things are pretty stormy out there right now."
No comments:
Post a Comment